Cerebrolysin
The Neuropeptide Mixture for Brain Repair
01
Overview
Cerebrolysin is a peptide preparation derived from porcine brain tissue consisting of low-molecular-weight peptides and free amino acids. It has been used clinically in Europe and Asia for over 50 years. Research documents its potent neurotrophic activity, functioning similarly to endogenous growth factors BDNF, NGF, and GDNF.
02
Mechanism of Action
The active neuropeptide fractions of Cerebrolysin cross the blood-brain barrier and modulate neuronal survival pathways including the MAPK/ERK and PI3K/Akt cascades. They reduce beta-amyloid production and tau hyperphosphorylation, and stimulate synaptic plasticity markers.
03
Research Highlights
Multiple RCTs demonstrate cognitive improvement in vascular dementia and Alzheimer's disease
Post-stroke studies show enhanced functional recovery and neurological improvement scores
Neurogenesis studies confirm new neuron formation in hippocampal dentate gyrus
04
Dosage
Administration & Timing
Intramuscular (IM) injection or slow IV infusion. Research protocols use daily administration, typically morning; approved in several countries for cerebrovascular disorders.
Dosage Guidelines
Cycle Length
2–4 weeks of daily administration, repeated 1–2× per year in chronic research.
05
Reconstitution
Solvent
Supplied as ready-to-use aqueous solution; dilute IV doses in 100–250 mL saline
Volume
Pre-filled ampoules (1, 2, 5, 10 mL)
Concentration
215 mg/mL peptide concentrate
Storage
Store ampoules at <25 °C; protect from light. Discard opened ampoule immediately.
Notes
Cerebrolysin is a porcine brain-derived peptide complex. IV infusion must be slow (1–2 mL/min) to avoid tolerability issues.
Research Reference Only
Dosage and reconstitution values reflect commonly cited ranges from published research literature and are presented for educational and research reference only. This is not medical advice or a dosing recommendation. HEXAGEN does not endorse human use of any compound. Always consult a qualified healthcare professional.
Research Disclaimer
Cerebrolysin is for educational and research purposes only. Not intended as medical advice. Consult a qualified healthcare professional before making any health-related decisions.
Related Compounds
View All
Cerebrolysin Knowledge Graph
Explore how Cerebrolysin connects to mechanisms, research goals, related compounds, research stacks, and scientific references. Drag nodes, zoom, and filter by type.
No nodes match the active filters.
Cerebrolysin — Common Research Questions
What is Cerebrolysin?
Cerebrolysin is a peptide preparation derived from porcine brain tissue consisting of low-molecular-weight peptides and free amino acids. It has been used clinically in Europe and Asia for over 50 yea... Cerebrolysin belongs to the Cognitive research category and is studied for its the neuropeptide mixture for brain repair.
How does Cerebrolysin work?
The active neuropeptide fractions of Cerebrolysin cross the blood-brain barrier and modulate neuronal survival pathways including the MAPK/ERK and PI3K/Akt cascades. They reduce beta-amyloid production and tau hyperphosphorylation, and stimulate synaptic plasticity markers.
What are the key research benefits of Cerebrolysin?
Neurotrophic support mimicking BDNF, NGF, and GDNF. Neurogenesis and synaptogenesis promotion. Neuroprotection against ischemic and excitotoxic damage. Alzheimer's disease research applications. Post-stroke cognitive rehabilitation. Traumatic brain injury recovery support.
What is the molecular structure of Cerebrolysin?
Cerebrolysin is a research compound in the Cognitive category. Detailed molecular structure data is being compiled. Refer to primary literature for structural analysis.
What does the research say about Cerebrolysin?
Multiple RCTs demonstrate cognitive improvement in vascular dementia and Alzheimer's disease Post-stroke studies show enhanced functional recovery and neurological improvement scores Neurogenesis studies confirm new neuron formation in hippocampal dentate gyrus These findings are based on preclinical and clinical research. Cerebrolysin is a research compound and these studies do not constitute medical advice.
Is Cerebrolysin FDA approved?
No. Cerebrolysin is not FDA-approved for any indication. It is a research chemical studied in preclinical and early clinical research. These compounds are not approved for human therapeutic use and should only be studied in appropriate research settings.
What category does Cerebrolysin belong to?
Cerebrolysin belongs to the Cognitive category, which focuses on peptides investigated for their nootropic and neuroprotective potential, supporting mental clarity, memory consolidation, and neurological resilience. You can explore more compounds in this category on the Cognitive pillar page.
Related Articles
Semax: BDNF Upregulation and Cognitive Enhancement
A review of Semax's mechanism — from melanocortin receptor modulation to BDNF and NGF upregulation in the hippocampus.
Dihexa: Synaptogenesis and Spatial Memory
Washington State University research on Dihexa's dramatic effects on synaptogenesis and Morris water maze performance.
Noopept: The Dipeptide Nootropic
Understanding Noopept's prodrug conversion, BDNF/NGF upregulation, and its position as a dipeptide nootropic.
Scientific References
Alvarez et al. — RCTs in vascular dementia and Alzheimer's (J Alzheimer's Dis, 2011)
Heiss et al. — Post-stroke recovery CASTA trial, Stroke, 2012
Multiple RCTs demonstrate cognitive improvement in vascular dementia and Alzheimer's disease
Post-stroke studies show enhanced functional recovery and neurological improvement scores
Neurogenesis studies confirm new neuron formation in hippocampal dentate gyrus